Skip to main content
Premium Trial:

Request an Annual Quote

Agilent's Fiscal Q4 Revenues Rise 6 Percent; Bio-Analytical Measurement Grows 9 Percent

NEW YORK (GenomeWeb News) — Agilent Technologies today said fiscal fourth-quarter revenues increased 6 percent as R&D spending fell 8 percent and profit surged 508 percent.
 
Total receipts for the three months ended Sept. 30 increased to $1.33 billion from $1.25 billion year over year.
 
Revenue for the company’s Bio-Analytical Measurement segment rose 9 percent to $418 million.
 
R&D spending decreased to $155 million from $168 million year over year.
 
The company said profit increased to $152 million from $25 million in the year-ago period, which included restructuring charges and other items.
 
Agilent said it had around $2.3 billion in cash and equivalents as of Sept. 30.
 
During the quarter, Agilent said its return on invested capital was at 29 percent, and the company issued a two-year, $2-billion stock repurchase program
 
The company said it expects fiscal first-quarter 2007 revenues to be between $1.25 billion and $1.29 billion, or between 7 percent and 10 percent better than the same quarter of 2006.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.